← Home India · nd-india

Expedited IND Pilot Targets Sequential Delays Slowing First-in-Human Trials

Source: pharmtech · 2026-10-19T05:30:00 UTC

Boyang Wang of Immortal Dragons explains how FDA's Expedited IND Pilot and QRIs could compress sequential first-in-human steps as China's Decree 818 raises the pace.

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Related in India

‘It’s very simple’ - Luis Enrique talks trying to stop Lamine Yamal and Barcelona

Barca Blaugranes

Amazon's New AI Wearables: What Bee Frontier and Bee Eclipse Can Do

NDTV Profit

Elon Musk Pledges 1 SpaceX Share For Every US Child, Plan Could Be Worth $10.5 Billion

NDTV

Manic Monday at Indian stock market: Sensex, Nifty bleed - ₹3.6 lakh cr gone in 6 hours

Livemint

Scientists Just Revived Pig Kidneys Frozen for a Year. It Could Rewrite the Future of Organ Transplants

Gizmodo

Royal Enfield Sales Breakup Sep 2026 - Classic, Bullet, Hunter, Meteor, Himalayan, 650 Twins

RushLane